As of 2026-03-31, 国药集团中国生物's data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 0.00%, below the industry average by 14.6 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 国药集团中国生物's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
国药集团中国生物's Mention Rate is 0.00%, lower than 0.6% of competitors
国药集团中国生物's First Mention is 0.00%, lower than 0.9% of competitors
国药集团中国生物's Preferred Rate is 0.00%, lower than 100.0% of competitors
国药集团中国生物's Positive Rate is 0.00%, lower than 8.9% of competitors
国药集团中国生物's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 强强生 | 37.5% | 14.58% | 28.57% | 29.17% | 10.42% | View Details |
| 辉辉瑞 | 37.5% | 8.33% | 28.57% | 22.92% | 10.42% | View Details |
| 恒恒瑞医药 | 8.33% | 4.17% | 7.14% | 8.33% | 2.08% | View Details |
| 百百济神州 | 4.17% | 0% | 0% | 4.17% | 0% | View Details |
| 华华东医药 | 0% | 0% | 0% | 0% | 0% | View Details |
| 和和黄医药 | 0% | 0% | 0% | 0% | 0% | View Details |
| 国国药集团中国生物 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
